Detalhe da pesquisa
1.
The path to successful commercialization of cell and gene therapies: empowering patient advocates.
Cytotherapy
; 19(2): 293-298, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27956199
2.
Generating health technology assessment evidence for rare diseases.
Int J Technol Assess Health Care
; 30(4): 416-22, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25407328
3.
A pilot study of multicriteria decision analysis for valuing orphan medicines.
Value Health
; 16(8): 1163-9, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24326170
4.
Unlocking sociocultural and community factors for the global adoption of genomic medicine.
Orphanet J Rare Dis
; 17(1): 191, 2022 05 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35549752
5.
Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective.
Orphanet J Rare Dis
; 17(1): 168, 2022 04 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35436894
6.
Population biobanks and returning individual research results: mission impossible or new directions?
Hum Genet
; 130(3): 393-401, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21643981
7.
Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine.
Cancers (Basel)
; 13(3)2021 Feb 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33540773
8.
Time for Change? The Why, What and How of Promoting Innovation to Tackle Rare Diseases - Is It Time to Update the EU's Orphan Regulation? And if so, What Should be Changed?
Biomed Hub
; 5(2): 1-11, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33564657
9.
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.
Biomed Hub
; 5(3): 182-223, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33564664
10.
Non-invasive prenatal diagnosis: public and patient perceptions.
Semin Fetal Neonatal Med
; 13(2): 109-12, 2008 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-18267309
11.
An assessment of written patient information provided at the genetic clinic and relating to genetic testing in seven European countries.
Eur J Hum Genet
; 15(10): 1012-22, 2007 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-17568389
12.
Safety of medicines and the use of animals in research.
Lancet
; 378(9786): 127-8, 2011 Jul 09.
Artigo
Inglês
| MEDLINE | ID: mdl-21719093
13.
Risk and Benefit in Personalised Medicine: An End User View.
New Bioeth
; 23(1): 49-54, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28517990
14.
EU Health Policy, Coherence, Stakeholder Diversity and Their Impact on the EMA.
Biomed Hub
; 2(Suppl 1): 191-201, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-31988949
15.
A Disruptive Dinner Guest.
Biomed Hub
; 2(Suppl 1): 26-28, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-31988927
16.
Implementing genetic education in primary care: the Gen-Equip programme.
J Community Genet
; 8(2): 147-150, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28289980
17.
Marketing of unproven stem cell-based interventions: A call to action.
Sci Transl Med
; 9(397)2017 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28679655
18.
DISCERN-Genetics: quality criteria for information on genetic testing.
Eur J Hum Genet
; 14(11): 1179-88, 2006 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-16868557
19.
Prevention of Congenital Disorders and Care of Affected Children: A Consensus Statement.
JAMA Pediatr
; 170(8): 790-3, 2016 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27366873
20.
Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness.
Eur J Hum Genet
; 23(6): 729-35, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25248395